These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 4615785
1. Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer. Ahmann DL, Bisel HF, Hahn RG. Cancer Chemother Rep; 1974; 58(6):861-5. PubMed ID: 4615785 [No Abstract] [Full Text] [Related]
2. Clinical trial of isophosphamide (NSC-109724)--results and side effects. Bremner DN, McCormick JS, Thomson JW. Cancer Chemother Rep; 1974; 58(6):889-93. PubMed ID: 4614898 [No Abstract] [Full Text] [Related]
9. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. Ahmann DL, Bisel HF, Eagan RT, Edmonson JH, Hahn RG. Cancer Chemother Rep; 1974; 58(6):877-82. PubMed ID: 4614896 [No Abstract] [Full Text] [Related]
10. Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. O'Connell TX, Berenbaum MC. Cancer Res; 1974 Jul; 34(7):1586-91. PubMed ID: 4833912 [No Abstract] [Full Text] [Related]
11. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs]. Norpoth K, Witting U, Rauen HM. Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116 [No Abstract] [Full Text] [Related]
12. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy]. Mouridsen HT, Palshof T, Brahm M, Rahbek I. Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742 [No Abstract] [Full Text] [Related]
13. Potentially useful combinations of chemotherapy detected in mouse tumor systems. Kline I. Cancer Chemother Rep 2; 1974 Mar 31; 4(1):33-43. PubMed ID: 4133187 [No Abstract] [Full Text] [Related]
14. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial. Heuson JC, Sylvester R, Engelsman E. Eur J Cancer (1965); 1980 Mar 31; Suppl 1():113-7. PubMed ID: 7032920 [No Abstract] [Full Text] [Related]
15. [Cytostatic combination therapy in metastatic breast cancer]. Mouridsen HT. Ugeskr Laeger; 1973 Jun 18; 135(25):1336-40. PubMed ID: 4757127 [No Abstract] [Full Text] [Related]
16. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma]. Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F. Internist (Berl); 1973 Dec 18; 14(12):643-52. PubMed ID: 4593011 [No Abstract] [Full Text] [Related]
17. Phase II study of combination cytotoxic chemotherapy in advanced breast cancer: 2 years' followup. Carmo-Pereira J, Teles AG, Costa FO, Pimentel P. Cancer Treat Rep; 1976 Jan 18; 60(1):107-9. PubMed ID: 187339 [No Abstract] [Full Text] [Related]
18. Combined chemo- and hormonal therapy in advanced breast cancer. Brunner KW, Sonntag RW, Alberto P, Senn HJ, Martz G, Obrecht P, Maurice P. Cancer; 1977 Jun 18; 39(6 Suppl):2923-33. PubMed ID: 326385 [No Abstract] [Full Text] [Related]
19. Adjuvant treatment of cancer. II. Breast carcinoma. Viola MV, Nystrom JS. Conn Med; 1977 Jun 18; 41(6):333-5. PubMed ID: 872584 [No Abstract] [Full Text] [Related]
20. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program. Muss HB, White DR, Cooper MR, Richards F, Spurr CL. Arch Intern Med; 1977 Dec 18; 137(12):1711-4. PubMed ID: 337916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]